Trials / Active Not Recruiting
Active Not RecruitingNCT04451863
Analgesic and Subjective Effects of Terpenes
Analgesic and Subjective Effects of Terpenes Administered Alone and in Combination With THC
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- University of California, Los Angeles · Academic / Other
- Sex
- All
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research is to assess the analgesic and subjective effects of terpenes administered alone and in combination of THC.
Detailed description
The overall aim of this placebo-controlled study is to examine dose-dependent analgesia, intoxication, abuse liability, and pharmacokinetics of ecologically relevant doses of vaporized myrcene and beta-caryophyllene administered alone or with vaporized THC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Low THC | Vaporized THC (5 mg) |
| DRUG | High THC | Vaporized THC (15 mg) |
| DRUG | Low Myrcene | Vaporized Myrcene (0.5 mg) |
| DRUG | High Myrcene | Vaporized Myrcene (12.0 mg) |
| DRUG | Low Beta-Caryophyllene | Vaporized Beta-Caryophyllene (0.5 mg) |
| DRUG | High Beta-Caryophyllene | Vaporized Beta-Caryophyllene (7.5 mg) |
| DRUG | Placebo | Vaporized Placebo |
Timeline
- Start date
- 2021-12-15
- Primary completion
- 2025-11-12
- Completion
- 2026-04-30
- First posted
- 2020-06-30
- Last updated
- 2025-12-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04451863. Inclusion in this directory is not an endorsement.